Foster & Motley’s CyrusOne Inc Common Stock CONE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-13,780
Closed -$1.24M 372
2021
Q4
$1.24M Sell
13,780
-18,023
-57% -$1.53M 0.1% 173
2021
Q3
$2.46M Sell
31,803
-18,601
-37% -$1.4M 0.21% 121
2021
Q2
$3.6M Sell
50,404
-9,791
-16% -$713K 0.3% 85
2021
Q1
$4.08M Sell
60,195
-517
-0.9% -$35.9K 0.34% 73
2020
Q4
$4.44M Buy
60,712
+5,829
+11% +$423K 0.43% 65
2020
Q3
$3.84M Buy
54,883
+255
+0.5% +$20K 0.45% 63
2020
Q2
$3.97M Buy
54,628
+18,620
+52% +$1.33M 0.5% 58
2020
Q1
$2.22M Buy
36,008
+10,296
+40% +$629K 0.33% 87
2019
Q4
$1.68M Buy
25,712
+21,125
+461% +$1.45M 0.21% 116
2019
Q3
$363K Sell
4,587
-10
-0.2% -$668 0.05% 208
2019
Q2
$265K Buy
+4,597
New +$269K 0.04% 222

Other funds holding CONE

Foster & Motley's CONE Position: Q1 2022 in Review

Foster & Motley sold out of CyrusOne Inc Common Stock (CONE) in Q1 2022, closing a stake of 13,780 shares — an estimated $1.24M sold.

Foster & Motley first reported a position in CONE in Q2 2019 and held it in 11 quarters. The position peaked at $4.44M in Q4 2020. 3 funds tracked by Wall St. Rank hold CONE as of Q1 2022.

  • Foster & Motley reported no remaining CyrusOne Inc Common Stock position as of Q1 2022 after selling out during the quarter.
  • Foster & Motley sold 13,780 CyrusOne Inc Common Stock shares in Q1 2022, an estimated $1.24M.
  • Foster & Motley first reported a position in CyrusOne Inc Common Stock in Q2 2019 and held it in 11 quarters.
  • Foster & Motley's CyrusOne Inc Common Stock position peaked at $4.44M in Q4 2020.
  • 3 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q1 2022.

Based on Foster & Motley's 13F filing for Q1 2022, filed 28 Apr 2022.